皮膜黑色素瘤的免疫瘤方法:tebentafusp及其他方面
C Gerard1,2, B Shum1,3, P Nathan4
1Cancer Dynamics Laboratory, The Francis Crick Institute, London, UK.
Immuno-oncology technology
|July 24, 2023
概括
卵巢黑色素瘤 (UM) 是一种罕见的眼睛癌症,预后不佳. 与其他免疫疗法不同,Tebentafusp提供了新的希望,显示转移性UM (mUM) 患者的生存率有所改善.
科学领域:
- 眼科医生 眼科 眼科
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
背景情况:
- 卵巢黑色素瘤 (UM) 是成年人中最常见的初级眼内恶性瘤.
- 转移性UM (mUM) 的预后不佳,治疗选择有限.
- 标准免疫检查点抑制剂在mUM中表现出较差的疗效.
研究的目的:
- 审查目前和新兴的免疫瘤治疗方法.
- 讨论预测对这些疗法的反应和耐药性的生物标志物.
- 建议UM治疗的未来研究方向.
主要方法:
- 对mUM的免疫瘤学方法的文献综述.
- 分析临床试验数据和研究出版物.
- 综合关于治疗疗效和生物标志物的信息.
主要成果:
- 泰班塔法斯普是第一个改善mUM整体存活率的治疗方法.
- 现有的免疫疗法对mUM的成功有限.
- 响应和耐药性的生物标志物正在研究中.
结论:
- 泰班塔法斯普代表了mUM治疗的重大进步.
- 需要进一步的研究来优化免疫疗法和确定预测生物标志物.
- 将治疗效益扩大到更多的UM患者是关键目标.
相关概念视频
01:27Tumor Immunotherapy
560
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
560
02:57Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K